Christopher Kim, Chairman and CMO: Apimeds Pharmaceuticals US APUS Buy · Filed 25/05/15

Trade details

Type: Insider buy
Amount: $35,981.4
Shares · price: 19,770 sh · $1.82 a share
Held after: 19,770 sh
Stock: Apimeds Pharmaceuticals US APUS
Person: Christopher KimChairman and CMO
Trade date: 25/05/13
Filed: 25/05/15
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 3 insiders

Apimeds Pharmaceuticals US trades, last 26 weeks

What else happened in Apimeds Pharmaceuticals US around then

Filed or reported within 30 days of the trade day · 25/04/13~25/06/12

Christopher Kim's recent trades

Christopher KimChairman and CMO
BuyApimeds Pharmaceuticals US
Buy
Apimeds Pharmaceuticals US
APUS
$14.4K
7,730 sh
$14.4K
Filed 25/05/15
Traded 25/05/14

Christopher Kim, Chairman — bought $36K of Apimeds Pharmaceuticals US APUS · 19,770 sh @ $1.82 | Whalegun